Surface Oncology Ownership 2024 | Who Owns Surface Oncology Now?


OverviewChart

Institutional Ownership

32.07%

Insider Ownership

7.28%

Retail Ownership

60.65%

Institutional Holders

62.00

Surface Oncology Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
FRANKLIN RESOURCES INC----57,360-100.00%-Sep 30, 2023
WELLS FARGO & COMPANY/MN----880-100.00%-Sep 30, 2023
NORTHERN TRUST CORP----86,824-100.00%-Sep 30, 2023
FMR LLC----232,815-100.00%-Sep 30, 2023
STIFEL FINANCIAL CORP----376,750-100.00%-Sep 30, 2023
CITIGROUP INC----37,657-100.00%-Sep 30, 2023
CHARLES SCHWAB INVESTMENT MANAGEMENT INC----44,721-100.00%-Sep 30, 2023
MORGAN STANLEY----35,366-100.00%-Sep 30, 2023
ACADIAN ASSET MANAGEMENT LLC----868,620-100.00%-Sep 30, 2023
GROUP ONE TRADING, L.P.----6,774-100.00%-Sep 30, 2023
ROYAL BANK OF CANADA----24,432-100.00%-Sep 30, 2023
COMMERCE BANK----20,000-100.00%-Sep 30, 2023
FEDERATED HERMES, INC.----2,638-100.00%-Sep 30, 2023
KEYBANK NATIONAL ASSOCIATION/OH----26,455-100.00%-Sep 30, 2023
CSS LLC/IL----10,740-100.00%-Sep 30, 2023
EQUITEC PROPRIETARY MARKETS, LLC----20,198-100.00%-Sep 30, 2023
BNP PARIBAS ARBITRAGE, SNC----1-100.00%-Sep 30, 2023
TWO SIGMA INVESTMENTS, LP----38,317-100.00%-Sep 30, 2023
GEODE CAPITAL MANAGEMENT, LLC----667,418-100.00%-Sep 30, 2023
BLACKROCK INC.----520,886-100.00%-Sep 30, 2023

Surface Oncology's largest institutional shareholder is FRANKLIN RESOURCES INC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
FRANKLIN RESOURCES INC----57,360-100.00%-Sep 30, 2023
WELLS FARGO & COMPANY/MN----880-100.00%-Sep 30, 2023
NORTHERN TRUST CORP----86,824-100.00%-Sep 30, 2023
FMR LLC----232,815-100.00%-Sep 30, 2023
STIFEL FINANCIAL CORP----376,750-100.00%-Sep 30, 2023
CITIGROUP INC----37,657-100.00%-Sep 30, 2023
CHARLES SCHWAB INVESTMENT MANAGEMENT INC----44,721-100.00%-Sep 30, 2023
MORGAN STANLEY----35,366-100.00%-Sep 30, 2023
ACADIAN ASSET MANAGEMENT LLC----868,620-100.00%-Sep 30, 2023
GROUP ONE TRADING, L.P.----6,774-100.00%-Sep 30, 2023
ROYAL BANK OF CANADA----24,432-100.00%-Sep 30, 2023
COMMERCE BANK----20,000-100.00%-Sep 30, 2023
FEDERATED HERMES, INC.----2,638-100.00%-Sep 30, 2023
KEYBANK NATIONAL ASSOCIATION/OH----26,455-100.00%-Sep 30, 2023
CSS LLC/IL----10,740-100.00%-Sep 30, 2023
EQUITEC PROPRIETARY MARKETS, LLC----20,198-100.00%-Sep 30, 2023
BNP PARIBAS ARBITRAGE, SNC----1-100.00%-Sep 30, 2023
TWO SIGMA INVESTMENTS, LP----38,317-100.00%-Sep 30, 2023
GEODE CAPITAL MANAGEMENT, LLC----667,418-100.00%-Sep 30, 2023
BLACKROCK INC.----520,886-100.00%-Sep 30, 2023

The largest Surface Oncology shareholder by % of total assets is FRANKLIN RESOURCES INC. The company owns 0.00 shares of Surface Oncology (SURF), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BNP PARIBAS ARBITRAGE, SNC----1-100.00%-Sep 30, 2023
NEWSQUARE CAPITAL LLC----80-100.00%-Sep 30, 2023
CORNERSTONE PLANNING GROUP LLC----250-100.00%-Sep 30, 2023
NEWBRIDGE FINANCIAL SERVICES GROUP, INC.----405-100.00%-Sep 30, 2023
LARSON FINANCIAL GROUP LLC----751-100.00%-Sep 30, 2023
WELLS FARGO & COMPANY/MN----880-100.00%-Sep 30, 2023
FINANCIAL MANAGEMENT PROFESSIONALS, INC.----1,000-100.00%-Sep 30, 2023
ANTONETTI CAPITAL MANAGEMENT LLC----1,200-100.00%-Sep 30, 2023
FEDERATED HERMES, INC.----2,638-100.00%-Sep 30, 2023
TOWER RESEARCH CAPITAL LLC (TRC)----6,726-100.00%-Sep 30, 2023
GROUP ONE TRADING, L.P.----6,774-100.00%-Sep 30, 2023
UBS GROUP AG----6,875-100.00%-Sep 30, 2023
GROUND SWELL CAPITAL, LLC----10,155-100.00%-Sep 30, 2023
ADVISOR GROUP HOLDINGS, INC.----10,450-100.00%-Sep 30, 2023
CSS LLC/IL----10,740-100.00%-Sep 30, 2023
PLATFORM TECHNOLOGY PARTNERS----11,000-100.00%-Sep 30, 2023
RIA ADVISORY GROUP LLC----12,000-100.00%-Sep 30, 2023
VIRTU FINANCIAL LLC----12,230-100.00%-Sep 30, 2023
FORMIDABLE ASSET MANAGEMENT, LLC----15,175-100.00%-Sep 30, 2023
PRIVATE ADVISOR GROUP, LLC----17,325-100.00%-Sep 30, 2023

As of Sep 30 2023, Surface Oncology's largest institutional buyer is BNP PARIBAS ARBITRAGE, SNC. The company purchased -1.00 stocks of SURF, valued at -.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ARMISTICE CAPITAL, LLC----4,890,000-100.00%-Sep 30, 2023
ATLAS VENTURE ASSOCIATES IX, LLC----2,945,453-100.00%-Sep 30, 2023
ARK INVESTMENT MANAGEMENT LLC----1,412,077-100.00%-Sep 30, 2023
DAFNA CAPITAL MANAGEMENT LLC----1,100,000-100.00%-Sep 30, 2023
ACADIAN ASSET MANAGEMENT LLC----868,620-100.00%-Sep 30, 2023
YAKIRA CAPITAL MANAGEMENT, INC.----785,879-100.00%-Sep 30, 2023
GEODE CAPITAL MANAGEMENT, LLC----667,418-100.00%-Sep 30, 2023
BLACKROCK INC.----520,886-100.00%-Sep 30, 2023
STIFEL FINANCIAL CORP----376,750-100.00%-Sep 30, 2023
BLACK MAPLE CAPITAL MANAGEMENT LP----266,736-100.00%-Sep 30, 2023
FMR LLC----232,815-100.00%-Sep 30, 2023
KNIGHTS OF COLUMBUS ASSET ADVISORS LLC----157,769-100.00%-Sep 30, 2023
BANK OF NEW YORK MELLON CORP----132,393-100.00%-Sep 30, 2023
NORTHERN TRUST CORP----86,824-100.00%-Sep 30, 2023
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC----64,875-100.00%-Sep 30, 2023
FRANKLIN RESOURCES INC----57,360-100.00%-Sep 30, 2023
ARETE WEALTH ADVISORS, LLC----54,465-100.00%-Sep 30, 2023
CHARLES SCHWAB INVESTMENT MANAGEMENT INC----44,721-100.00%-Sep 30, 2023
EAGLE ROCK INVESTMENT COMPANY, LLC----42,000-100.00%-Sep 30, 2023
TWO SIGMA INVESTMENTS, LP----38,317-100.00%-Sep 30, 2023

As of Sep 30 2023, Surface Oncology's biggest institutional seller is ARMISTICE CAPITAL, LLC. The company sold -4.89M shares of SURF, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ARMISTICE CAPITAL, LLC----4,890,000-100.00%-Sep 30, 2023
ATLAS VENTURE ASSOCIATES IX, LLC----2,945,453-100.00%-Sep 30, 2023
ARK INVESTMENT MANAGEMENT LLC----1,412,077-100.00%-Sep 30, 2023
DAFNA CAPITAL MANAGEMENT LLC----1,100,000-100.00%-Sep 30, 2023
ACADIAN ASSET MANAGEMENT LLC----868,620-100.00%-Sep 30, 2023
YAKIRA CAPITAL MANAGEMENT, INC.----785,879-100.00%-Sep 30, 2023
GEODE CAPITAL MANAGEMENT, LLC----667,418-100.00%-Sep 30, 2023
BLACKROCK INC.----520,886-100.00%-Sep 30, 2023
STIFEL FINANCIAL CORP----376,750-100.00%-Sep 30, 2023
BLACK MAPLE CAPITAL MANAGEMENT LP----266,736-100.00%-Sep 30, 2023
FMR LLC----232,815-100.00%-Sep 30, 2023
KNIGHTS OF COLUMBUS ASSET ADVISORS LLC----157,769-100.00%-Sep 30, 2023
BANK OF NEW YORK MELLON CORP----132,393-100.00%-Sep 30, 2023
NORTHERN TRUST CORP----86,824-100.00%-Sep 30, 2023
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC----64,875-100.00%-Sep 30, 2023
FRANKLIN RESOURCES INC----57,360-100.00%-Sep 30, 2023
ARETE WEALTH ADVISORS, LLC----54,465-100.00%-Sep 30, 2023
CHARLES SCHWAB INVESTMENT MANAGEMENT INC----44,721-100.00%-Sep 30, 2023
EAGLE ROCK INVESTMENT COMPANY, LLC----42,000-100.00%-Sep 30, 2023
TWO SIGMA INVESTMENTS, LP----38,317-100.00%-Sep 30, 2023
CITIGROUP INC----37,657-100.00%-Sep 30, 2023
MORGAN STANLEY----35,366-100.00%-Sep 30, 2023
TWO SIGMA SECURITIES, LLC----27,577-100.00%-Sep 30, 2023
KEYBANK NATIONAL ASSOCIATION/OH----26,455-100.00%-Sep 30, 2023
TWO SIGMA ADVISERS, LP----25,900-100.00%-Sep 30, 2023
ROYAL BANK OF CANADA----24,432-100.00%-Sep 30, 2023
SIMPLEX TRADING, LLC----20,332-100.00%-Sep 30, 2023
EQUITEC PROPRIETARY MARKETS, LLC----20,198-100.00%-Sep 30, 2023
COMMERCE BANK----20,000-100.00%-Sep 30, 2023
PRIVATE ADVISOR GROUP, LLC----17,325-100.00%-Sep 30, 2023
FORMIDABLE ASSET MANAGEMENT, LLC----15,175-100.00%-Sep 30, 2023
VIRTU FINANCIAL LLC----12,230-100.00%-Sep 30, 2023
RIA ADVISORY GROUP LLC----12,000-100.00%-Sep 30, 2023
PLATFORM TECHNOLOGY PARTNERS----11,000-100.00%-Sep 30, 2023
CSS LLC/IL----10,740-100.00%-Sep 30, 2023
ADVISOR GROUP HOLDINGS, INC.----10,450-100.00%-Sep 30, 2023
GROUND SWELL CAPITAL, LLC----10,155-100.00%-Sep 30, 2023
UBS GROUP AG----6,875-100.00%-Sep 30, 2023
GROUP ONE TRADING, L.P.----6,774-100.00%-Sep 30, 2023
TOWER RESEARCH CAPITAL LLC (TRC)----6,726-100.00%-Sep 30, 2023
FEDERATED HERMES, INC.----2,638-100.00%-Sep 30, 2023
ANTONETTI CAPITAL MANAGEMENT LLC----1,200-100.00%-Sep 30, 2023
FINANCIAL MANAGEMENT PROFESSIONALS, INC.----1,000-100.00%-Sep 30, 2023
WELLS FARGO & COMPANY/MN----880-100.00%-Sep 30, 2023
LARSON FINANCIAL GROUP LLC----751-100.00%-Sep 30, 2023
NEWBRIDGE FINANCIAL SERVICES GROUP, INC.----405-100.00%-Sep 30, 2023
CORNERSTONE PLANNING GROUP LLC----250-100.00%-Sep 30, 2023
NEWSQUARE CAPITAL LLC----80-100.00%-Sep 30, 2023
BNP PARIBAS ARBITRAGE, SNC----1-100.00%-Sep 30, 2023

Surface Oncology's largest sold out institutional shareholder by shares sold is ARMISTICE CAPITAL, LLC, sold -4.89M shares, valued at -, as of undefined.

Surface Oncology Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
CORNERCAP GROUP OF FUNDS /VA/0.77%55,37820,17057.29%Sep 30, 2022
DELAWARE GROUP EQUITY FUNDS IV0.30%350,000--Mar 28, 2024
BRIDGEWAY FUNDS INC0.06%132,500--Mar 28, 2024
Collaborative Investment Series Trust0.05%8,291--Mar 31, 2024
VANGUARD VALLEY FORGE FUNDS0.05%24,474--Mar 31, 2024
PIMCO Dynamic Credit & Mortgage Income Fund0.04%2,901,146-25,350-0.87%Sep 30, 2021
Vericimetry Funds0.04%3,280--Mar 31, 2024
PIMCO Dynamic Income Fund0.02%2,446,915-35,086-1.41%Mar 31, 2024
TARGET PORTFOLIO TRUST0.01%274,300--Jan 31, 2024
Fidelity Commonwealth Trust II0.01%60,289--Aug 31, 2023
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.01%5,050--Mar 31, 2024
QUANTITATIVE MASTER SERIES LLC0.01%50,001--Mar 31, 2024
VICTORY PORTFOLIOS0.01%218,630--Mar 31, 2024
VANGUARD INDEX FUNDS0.01%2,245,943--Mar 31, 2024
TIAA SEPARATE ACCOUNT VA 10.00%956--Mar 31, 2024
Principal Exchange-Traded Funds0.00%44,105--Mar 31, 2024
ALPS ETF Trust0.00%45,468--Feb 29, 2024
FIDELITY CONCORD STREET TRUST0.00%637,511--Feb 29, 2024
Legg Mason ETF Investment Trust0.00%5,854--Mar 31, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.00%32,938--Mar 31, 2024
BAIRD FUNDS INC0.00%3,043,230--Mar 31, 2024
Managed Portfolio Series0.00%55,378--Jan 31, 2024
GPS Funds I0.00%13,253--Mar 31, 2024
TRUST FOR PROFESSIONAL MANAGERS0.00%755,872-12,454-1.62%Feb 29, 2024
FIDELITY SELECT PORTFOLIOS0.00%144,645--Feb 29, 2024
Voya VARIABLE PORTFOLIOS INC0.00%64,313--Mar 31, 2024
PRUDENTIAL INVESTMENT PORTFOLIOS, INC.0.00%18,200--Mar 28, 2024
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.00%5,999--Mar 31, 2024
RBB FUND, INC.0.00%114,949--Feb 29, 2024
SCHWAB CAPITAL TRUST0.00%44,721--Feb 29, 2024
Advisors' Inner Circle Fund III0.00%115,930--Jan 31, 2024
Calvert Variable Products, Inc.0.00%2,609--Mar 31, 2024
ALLSPRING MASTER TRUST0.00%45,391--Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%20,025--Mar 31, 2024
JPMorgan Trust I0.00%541,476--Jan 31, 2024
AdvisorShares Trust0.00%1,667--Mar 28, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%1,500--Mar 31, 2024
TIAA-CREF LIFE FUNDS0.00%719--Mar 31, 2024
Global X Funds0.00%10,071--Jan 31, 2024
RBC FUNDS TRUST0.00%23,000--Mar 28, 2024
Goldman Sachs ETF Trust0.00%16,713--Feb 29, 2024
FLEXSHARES TRUST0.00%12,220--Jan 31, 2024
HC CAPITAL TRUST0.00%5,000--Mar 31, 2024
NORTHERN FUNDS0.00%17,462--Mar 28, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%6,600--Mar 31, 2024
RYDEX SERIES FUNDS0.00%337--Dec 31, 2023
ProFunds0.00%756--Mar 31, 2024
Invesco Exchange-Traded Fund Trust II0.00%19,303--Jan 31, 2024
FIDELITY SALEM STREET TRUST0.00%243,450--Mar 31, 2024
VANGUARD SCOTTSDALE FUNDS0.00%117,887--Feb 29, 2024
T. Rowe Price Index Trust, Inc.0.00%1,318--Feb 29, 2024
GMO TRUST0.00%71,288--Feb 29, 2024
Invesco Exchange-Traded Self-Indexed Fund Trust0.00%10,947--Feb 29, 2024
MASTER INVESTMENT PORTFOLIO0.00%4,415--Mar 31, 2024
RYDEX DYNAMIC FUNDS0.00%187--Dec 31, 2023
VALIC Co I0.00%13,101--Feb 29, 2024
PENN SERIES FUNDS INC0.00%1,300--Mar 28, 2024
PIMCO FUNDS0.00%1,880,434-5,272,310-73.71%Mar 31, 2024
LAZARD FUNDS INC0.00%1,490--Mar 31, 2024
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST0.00%1,866--Dec 31, 2023
Guggenheim Active Allocation Fund0.00%208--Feb 29, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%4,438--Mar 31, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%33,498--Mar 31, 2024
RYDEX VARIABLE TRUST0.00%33--Dec 31, 2023
Bridge Builder Trust0.00%119,411--Mar 31, 2024
TIAA-CREF FUNDS0.00%78,139--Mar 31, 2024
USAA MUTUAL FUNDS TRUST0.00%5,635--Jan 31, 2024
NATIONWIDE MUTUAL FUNDS0.00%3,153--Jan 31, 2024
WisdomTree Trust0.00%48,352--Feb 29, 2024
PROSHARES TRUST0.00%4,881--Feb 29, 2024
SEI INSTITUTIONAL MANAGED TRUST0.00%49,177--Dec 31, 2023
Advisors' Inner Circle Fund II0.00%14,410--Jan 31, 2024
MORGAN STANLEY PATHWAY FUNDS0.00%1,332--Feb 29, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%28,600--Mar 31, 2024
WILSHIRE MUTUAL FUNDS INC0.00%3,530--Dec 31, 2023
ETF Series Solutions0.00%208--Jan 31, 2024
BLACKROCK FUNDS0.00%58,721--Mar 28, 2024
Ark ETF Trust0.00%65--Jan 31, 2024
iSHARES TRUST0.00%118,464--Mar 31, 2024
Legg Mason Global Asset Management Trust0.00%54,947--Jan 31, 2024
EQ ADVISORS TRUST0.00%8,059--Mar 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%6,842--Jan 31, 2024
SUNAMERICA SERIES TRUST0.00%2,413--Mar 31, 2024
SUNAMERICA SERIES TRUST0.00%2,413--Jan 31, 2024
PACIFIC SELECT FUND0.00%18,531--Mar 31, 2024
AMERICAN CENTURY ETF TRUST0.00%462--Feb 29, 2024
Bridge Builder Trust0.00%13,471--Mar 31, 2024
MASSMUTUAL SELECT FUNDS0.00%2,685--Dec 31, 2023
SEI INSTITUTIONAL INVESTMENTS TRUST0.00%53,940--Feb 29, 2024
BlackRock Variable Series Funds, Inc.0.00%3,969--Mar 31, 2024
Meeder Funds0.00%3--Mar 31, 2024
RUSSELL INVESTMENT CO0.00%182--Jan 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%1,145--Mar 31, 2024
PRINCIPAL FUNDS, INC.0.00%2,229--Feb 29, 2024
John Hancock Funds II0.00%4,260--Feb 29, 2024

Surface Oncology's largest mutual fund holder by % of total assets is "CORNERCAP GROUP OF FUNDS /VA/", owning 55.38K shares, compromising 0.77% of its total assets.

Surface Oncology Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 2362-12.68%
31 Mar, 2371-11.25%
31 Dec, 22803.90%
30 Sep, 2277-11.49%
30 Jun, 2287-18.69%
31 Mar, 22107-1.83%
31 Dec, 211097.92%
30 Sep, 21101-4.72%
30 Jun, 211069.28%
31 Mar, 21971.04%
31 Dec, 209662.71%
30 Sep, 205940.48%
30 Jun, 204250.00%
31 Mar, 2028-15.15%
31 Dec, 1933-2.94%
30 Sep, 1934-26.09%
30 Jun, 1946-14.81%
31 Mar, 195410.20%
31 Dec, 184911.36%
30 Sep, 1844-6.38%
30 Jun, 1847-
30 Jun, 101-

As of 30 Jun 23, 62 institutions are holding Surface Oncology's shares, representing a decrease of -12.68% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 2319,443,042-27.73%
31 Mar, 2326,904,171-5.70%
31 Dec, 2228,531,769-9.76%
30 Sep, 2231,618,3719.27%
30 Jun, 2228,935,089-9.33%
31 Mar, 2231,912,68129.35%
31 Dec, 2124,671,7752.52%
30 Sep, 2124,065,4596.56%
30 Jun, 2122,583,23419.47%
31 Mar, 2118,902,223-18.12%
31 Dec, 2023,084,7467.24%
30 Sep, 2021,526,787-2.94%
30 Jun, 2022,179,25462.34%
31 Mar, 2013,661,943-1.61%
31 Dec, 1913,885,123-5.71%
30 Sep, 1914,725,656-6.40%
30 Jun, 1915,731,950-4.29%
31 Mar, 1916,436,279-1.16%
31 Dec, 1816,628,934-4.80%
30 Sep, 1817,466,580-0.10%
30 Jun, 1817,483,878-
30 Jun, 101,500-

Surface Oncology (SURF) has 19.44M shares outstanding as of 30 Jun 23, down -27.73% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 2332.07%1.63%
31 Mar, 2344.38%2.00%
31 Dec, 2247.11%1.64%
30 Sep, 2253.54%1.91%
30 Jun, 2252.94%1.23%
31 Mar, 2265.66%2.11%
31 Dec, 2155.76%1.97%
30 Sep, 2153.20%1.99%
30 Jun, 2151.76%2.51%
31 Mar, 2145.42%1.08%
31 Dec, 2064.94%2.24%
30 Sep, 2053.81%1.22%
30 Jun, 2066.37%2.78%
31 Mar, 2048.83%1.97%
31 Dec, 1949.79%1.78%
30 Sep, 1952.85%1.66%
30 Jun, 1956.50%1.62%
31 Mar, 1959.07%0.85%
31 Dec, 1883.18%2.08%
30 Sep, 1863.29%0.97%
30 Jun, 1880.96%-
30 Jun, 100.01%-

As of 30 Jun 23, Surface Oncology is held by 32.07% institutional shareholders, representing a 1.63% growth compared to 31 Mar 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 2320-4.76%
31 Mar, 2321-22.22%
31 Dec, 2227-22.86%
30 Sep, 2235-25.53%
30 Jun, 2247-11.32%
31 Mar, 2253-5.36%
31 Dec, 21569.80%
30 Sep, 2151-22.73%
30 Jun, 216613.79%
31 Mar, 2158-10.77%
31 Dec, 206538.30%
30 Sep, 204756.67%
30 Jun, 2030233.33%
31 Mar, 209-
31 Dec, 199-18.18%
30 Sep, 1911-42.11%
30 Jun, 1919-32.14%
31 Mar, 1928-17.65%
31 Dec, 183421.43%
30 Sep, 1828-40.43%
30 Jun, 1847-
30 Jun, 101-

20 institutional shareholders have increased their position in SURF stock as of 30 Jun 23 compared to 21 in the previous quarter (a -4.76% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 2314-44.00%
31 Mar, 2325-16.67%
31 Dec, 223030.43%
30 Sep, 222315.00%
30 Jun, 2220-39.39%
31 Mar, 2233-
31 Dec, 213350.00%
30 Sep, 212257.14%
30 Jun, 2114-22.22%
31 Mar, 2118-
31 Dec, 2018125.00%
30 Sep, 20860.00%
30 Jun, 205-61.54%
31 Mar, 2013-18.75%
31 Dec, 1916-5.88%
30 Sep, 1917-15.00%
30 Jun, 192017.65%
31 Mar, 1917112.50%
31 Dec, 18814.29%
30 Sep, 187-
30 Jun, 18--
30 Jun, 10--

14 institutional shareholders have reduced their position in SURF stock as of 30 Jun 23 compared to 25 in the previous quarter (a -44.00% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 2362-12.68%19,443,042-27.73%32.07%1.63%20-4.76%14-44.00%
31 Mar, 2371-11.25%26,904,171-5.70%44.38%2.00%21-22.22%25-16.67%
31 Dec, 22803.90%28,531,769-9.76%47.11%1.64%27-22.86%3030.43%
30 Sep, 2277-11.49%31,618,3719.27%53.54%1.91%35-25.53%2315.00%
30 Jun, 2287-18.69%28,935,089-9.33%52.94%1.23%47-11.32%20-39.39%
31 Mar, 22107-1.83%31,912,68129.35%65.66%2.11%53-5.36%33-
31 Dec, 211097.92%24,671,7752.52%55.76%1.97%569.80%3350.00%
30 Sep, 21101-4.72%24,065,4596.56%53.20%1.99%51-22.73%2257.14%
30 Jun, 211069.28%22,583,23419.47%51.76%2.51%6613.79%14-22.22%
31 Mar, 21971.04%18,902,223-18.12%45.42%1.08%58-10.77%18-
31 Dec, 209662.71%23,084,7467.24%64.94%2.24%6538.30%18125.00%
30 Sep, 205940.48%21,526,787-2.94%53.81%1.22%4756.67%860.00%
30 Jun, 204250.00%22,179,25462.34%66.37%2.78%30233.33%5-61.54%
31 Mar, 2028-15.15%13,661,943-1.61%48.83%1.97%9-13-18.75%
31 Dec, 1933-2.94%13,885,123-5.71%49.79%1.78%9-18.18%16-5.88%
30 Sep, 1934-26.09%14,725,656-6.40%52.85%1.66%11-42.11%17-15.00%
30 Jun, 1946-14.81%15,731,950-4.29%56.50%1.62%19-32.14%2017.65%
31 Mar, 195410.20%16,436,279-1.16%59.07%0.85%28-17.65%17112.50%
31 Dec, 184911.36%16,628,934-4.80%83.18%2.08%3421.43%814.29%
30 Sep, 1844-6.38%17,466,580-0.10%63.29%0.97%28-40.43%7-
30 Jun, 1847-17,483,878-80.96%-47---
30 Jun, 101-1,500-0.01%-1---

Surface Oncology Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 11, 2023Adams Chandraofficer Deputy GCS-SaleSell3,901$0.94$3.67K30,899
Aug 11, 2023FEES JESSICAofficer Chief Financial OfficerS-SaleSell9,434$0.94$8.87K101,915
Aug 11, 2023ONEILL ALISONofficer Chief Medical OfficerS-SaleSell7,042$0.94$6.62K56,686
Aug 11, 2023ROSS ROBERT W.officer Chief Executive OfficerS-SaleSell16,713$0.94$15.71K83,193

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Sep 08, 2023Sigal Charles Elliottdirector-D-ReturnSell45,453---
Sep 08, 2023Sigal Charles Elliottdirector-D-ReturnSell113,636$0.35$39.77K-
Sep 08, 2023Adams Chandraofficer Deputy GCD-ReturnSell23,884---
Sep 08, 2023Adams Chandraofficer Deputy GCD-ReturnSell50,000$0.69$34.50K-
Sep 08, 2023RATH HENRY C.officer Chief Business OfficerD-ReturnSell44,971---
Sep 08, 2023RATH HENRY C.officer Chief Business OfficerD-ReturnSell150,000$0.69$103.50K-
Sep 08, 2023Goater Jeffdirector-D-ReturnSell129,222---
Sep 08, 2023Palombella Vito J.officer Chief Scientific OfficerD-ReturnSell87,212---
Sep 08, 2023Palombella Vito J.officer Chief Scientific OfficerD-ReturnSell150,000$0.69$103.50K-
Sep 08, 2023FEES JESSICAofficer Chief Financial OfficerD-ReturnSell101,915---
Sep 08, 2023FEES JESSICAofficer Chief Financial OfficerD-ReturnSell150,000$0.69$103.50K-
Sep 08, 2023ROSS ROBERT W.director, officer Chief Executive OfficerD-ReturnSell83,193---
Sep 08, 2023ROSS ROBERT W.director, officer Chief Executive OfficerD-ReturnSell400,000$0.69$276.00K-
Sep 08, 2023GRAYZEL DAVID S.director-D-ReturnSell2,945,453---
Sep 08, 2023ONEILL ALISONofficer Chief Medical OfficerD-ReturnSell56,686---
Sep 08, 2023ONEILL ALISONofficer Chief Medical OfficerD-ReturnSell150,000$0.69$103.50K-
Aug 11, 2023Adams Chandraofficer Deputy GCS-SaleSell3,901$0.94$3.67K30,899
Aug 11, 2023FEES JESSICAofficer Chief Financial OfficerS-SaleSell9,434$0.94$8.87K101,915
Aug 11, 2023ONEILL ALISONofficer Chief Medical OfficerS-SaleSell7,042$0.94$6.62K56,686
Aug 11, 2023ROSS ROBERT W.officer Chief Executive OfficerS-SaleSell16,713$0.94$15.71K83,193

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Sep 08, 2023Sigal Charles Elliottdirector-D-ReturnSell45,453---
Sep 08, 2023Sigal Charles Elliottdirector-D-ReturnSell113,636$0.35$39.77K-
Sep 08, 2023Adams Chandraofficer Deputy GCD-ReturnSell23,884---
Sep 08, 2023Adams Chandraofficer Deputy GCD-ReturnSell50,000$0.69$34.50K-
Sep 08, 2023RATH HENRY C.officer Chief Business OfficerD-ReturnSell44,971---
Sep 08, 2023RATH HENRY C.officer Chief Business OfficerD-ReturnSell150,000$0.69$103.50K-
Sep 08, 2023Goater Jeffdirector-D-ReturnSell129,222---
Sep 08, 2023Palombella Vito J.officer Chief Scientific OfficerD-ReturnSell87,212---
Sep 08, 2023Palombella Vito J.officer Chief Scientific OfficerD-ReturnSell150,000$0.69$103.50K-
Sep 08, 2023FEES JESSICAofficer Chief Financial OfficerD-ReturnSell101,915---
Sep 08, 2023FEES JESSICAofficer Chief Financial OfficerD-ReturnSell150,000$0.69$103.50K-
Sep 08, 2023ROSS ROBERT W.director, officer Chief Executive OfficerD-ReturnSell83,193---
Sep 08, 2023ROSS ROBERT W.director, officer Chief Executive OfficerD-ReturnSell400,000$0.69$276.00K-
Sep 08, 2023GRAYZEL DAVID S.director-D-ReturnSell2,945,453---
Sep 08, 2023ONEILL ALISONofficer Chief Medical OfficerD-ReturnSell56,686---
Sep 08, 2023ONEILL ALISONofficer Chief Medical OfficerD-ReturnSell150,000$0.69$103.50K-
Aug 11, 2023Adams Chandraofficer Deputy GCS-SaleSell3,901$0.94$3.67K30,899
Aug 11, 2023FEES JESSICAofficer Chief Financial OfficerS-SaleSell9,434$0.94$8.87K101,915
Aug 11, 2023ONEILL ALISONofficer Chief Medical OfficerS-SaleSell7,042$0.94$6.62K56,686
Aug 11, 2023ROSS ROBERT W.officer Chief Executive OfficerS-SaleSell16,713$0.94$15.71K83,193

The last insider sell of Surface Oncology's stock was made by Sigal Charles Elliott on Sep 08 2023, selling 45,453 shares at - per share (valued at -).

Surface Oncology Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2023-20-
Q1 20236--
Q4 20221250.00%
Q3 2022-5-
Q2 202210--
Q1 20228--
Q4 2021---
Q3 20211616.67%
Q2 2021155300.00%
Q1 202181172.73%
Q4 202061442.86%
Q3 2020-1-
Q2 202071700.00%
Q1 202015--
Q4 20195--
Q3 20194--
Q2 201981800.00%
Q1 201993300.00%
Q4 2018-6-
Q3 20182--

0 total buy trades, and 20 total sell trades (buy/sell ratio of 0.00%) were made by Surface Oncology's insiders, as of Q3 2023.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2023-4-
Q1 2023---
Q4 2022---
Q3 2022-5-
Q2 2022---
Q1 2022---
Q4 2021---
Q3 2021-6-
Q2 2021-2-
Q1 2021-8-
Q4 2020-8-
Q3 2020-1-
Q2 2020-1-
Q1 20201--
Q4 2019---
Q3 2019---
Q2 2019---
Q1 2019---
Q4 2018---
Q3 2018---

As of Q3 2023, Insider owners conducted 0 open market buy trades and 4 open market sell trades of Surface Oncology's stocks.

Surface Oncology Peer Ownership


TickerCompany
PSNLPersonalis, Inc.
EVGNEvogene Ltd.
IOVAIovance Biotherapeutics, Inc.
RPTXRepare Therapeutics Inc.
SYRSSyros Pharmaceuticals, Inc.

SURF Ownership FAQ


Surface Oncology is owned by institutional shareholders (32.07%), insiders (7.28%), and public (60.65%). The largest institutional shareholder of Surface Oncology is FRANKLIN RESOURCES INC (0% of total shares) and the top mutual fund owner is CORNERCAP GROUP OF FUNDS /VA/ (0.77% of total shares).

Surface Oncology's major institutional shareholders are FRANKLIN RESOURCES INC, WELLS FARGO & COMPANY/MN, NORTHERN TRUST CORP, FMR LLC, and STIFEL FINANCIAL CORP. The top five shareholders own together 0% of the company's share outstanding.

As of Jun 2023, there are 62 institutional shareholders of Surface Oncology.

FRANKLIN RESOURCES INC owns 0 shares of Surface Oncology, representing 0% of the company's total shares outstanding, valued at $0 (as of Sep 2023).

As of Sep 2023, WELLS FARGO & COMPANY/MN holds 0 shares of Surface Oncology (SURF), compromising 0% of the company, valued at $0.

NORTHERN TRUST CORP is the third largest holder of Surface Oncology. The company owns 0 of the company's shares outstanding (worth $0).